Genxone (WAR:GX1) EV-to-Revenue : 6.93 (As of Jun. 03, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Genxone EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Genxone's enterprise value is zł13.96 Mil. Genxone's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was zł2.01 Mil. Therefore, Genxone's EV-to-Revenue for today is 6.93.

The historical rank and industry rank for Genxone's EV-to-Revenue or its related term are showing as below:

WAR:GX1' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.12 Med: 3.46 Max: 25.63
Current: 6.93

During the past 6 years, the highest EV-to-Revenue of Genxone was 25.63. The lowest was 1.12. And the median was 3.46.

WAR:GX1's EV-to-Revenue is ranked better than
53.33% of 1035 companies
in the Biotechnology industry
Industry Median: 8.2 vs WAR:GX1: 6.93

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-03), Genxone's stock price is zł6.18. Genxone's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was zł0.61. Therefore, Genxone's PS Ratio for today is 10.13.

Genxone EV-to-Revenue Historical Data

The historical data trend for Genxone's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genxone EV-to-Revenue Chart

Genxone Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

3.08

2.37

2.13

4.48

Genxone Quarterly Data
	Mar19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															4.56	7.32	5.34	4.48	6.74

Competitive Comparison of Genxone's EV-to-Revenue

For the Biotechnology subindustry, Genxone's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genxone's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genxone's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Genxone's EV-to-Revenue falls into.

Genxone EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Genxone's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	13.956	/	2.013
	=	6.93

Genxone's current Enterprise Value is zł13.96 Mil.
Genxone's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł2.01 Mil.

Genxone (WAR:GX1) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Genxone's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	6.18	/	0.61
	=	10.13

Genxone's share price for today is zł6.18.
Genxone's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.61.

Genxone EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Genxone's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Genxone (WAR:GX1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genxone SA (WAR:GX1) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

ul. Kobaltowa 6, Zlotniki, Suchy Las, POL, 62-002

Website

https://www.genxone.eu

Genxone SA is a biotechnology company that applies nanopore sequencing technology (third-generation of NGS) to many areas of science and business, including genetic diagnostics and the food industry. It specializes in developing new products and solutions based on the latest technologies of nucleic acid sequencing. The company's services include NANOPORE SEQUENCING that includes Whole Genome Sequencing, Bespoke Analysis, Metagenome Sequencing, Bioinformatic Analysis, 16S and/or ITS Gene Sequencing, and RNA Sequencing; and DIAGNOSTIC TESTS that includes Gastrointestinal Infections Panel, Respiratory Infections Panel, Urogenital Infection Panel, and Nervous System Infection Panel.

Genxone (WAR:GX1) Headlines

No Headlines